new_0222_0430|OMIC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0430|OMIC|1|Singular Genomics Systems Inc Total Current Assets (Quarterly) (USD)|Singular Genomics Systems Inc Cash and Short Term Investments (Quarterly) (USD)|Singular Genomics Systems Inc Inventories (Quarterly) (USD)|Singular Genomics Systems Inc Net PP&E (Quarterly) (USD)|Singular Genomics Systems Inc Goodwill and Intangibles (Quarterly) (USD)|Singular Genomics Systems Inc Total Liabilities (Quarterly) (USD)|Singular Genomics Systems Inc Total Current Liabilities (Quarterly) (USD)|Singular Genomics Systems Inc Total Long Term Liabilities (Quarterly) (USD)|Singular Genomics Systems Inc Total Deposits (Quarterly) (USD)|Singular Genomics Systems Inc Book Value (Quarterly) (USD)|Singular Genomics Systems Inc Retained Earnings (Quarterly) (USD)|Singular Genomics Systems Inc Treasury Stock (Quarterly) (USD)|Singular Genomics Systems Inc EV to Revenues|Singular Genomics Systems Inc EV to Earnings|Singular Genomics Systems Inc EV to Free Cash Flow|Singular Genomics Systems Inc EV to Assets (Quarterly)|Singular Genomics Systems Inc PS Ratio|Singular Genomics Systems Inc PE Ratio|Singular Genomics Systems Inc Price to Book Value|Singular Genomics Systems Inc PEG Ratio|Singular Genomics Systems Inc Debt to Equity Ratio|Singular Genomics Systems Inc Dividend Yield|Singular Genomics Systems Inc Shareholder Yield (TTM)|Singular Genomics Systems Inc Percent of Shares Outstanding Short|Singular Genomics Systems Inc Total Receivables (Quarterly) (USD)|Singular Genomics Systems Inc Total Payables (Quarterly) (USD)|Singular Genomics Systems Inc Total Capital Stock (Quarterly) (USD)|Singular Genomics Systems Inc Return on Invested Capital|Singular Genomics Systems Inc Quality Ratio Score|Singular Genomics Systems Inc Momentum Score|Singular Genomics Systems Inc Beta (1Y)|Singular Genomics Systems Inc Sustainable Growth Rate (TTM)|Singular Genomics Systems Inc Institutional Investor Ownership Percentage|Singular Genomics Systems Inc Average Diluted Shares Outstanding (Quarterly)|Singular Genomics Systems Inc Total Employees (Annual)|Singular Genomics Systems Inc EPS Diluted (Quarterly) (USD)|Singular Genomics Systems Inc Shares Outstanding|Singular Genomics Systems Inc Repurchase of Capital Stock (Quarterly) (USD)|Singular Genomics Systems Inc Ordinary Shares Number (Quarterly)|Singular Genomics Systems Inc Payout Ratio|Singular Genomics Systems Inc Quick Ratio (Quarterly)|Singular Genomics Systems Inc Normalized Diluted EPS (Quarterly) (USD)|Singular Genomics Systems Inc Stock Buybacks (Quarterly) (USD)|Singular Genomics Systems Inc Effective Tax Rate (TTM)|Singular Genomics Systems Inc Return on Equity|Singular Genomics Systems Inc Net Income (TTM) (USD)|Singular Genomics Systems Inc Revenue (TTM) (USD)|Singular Genomics Systems Inc Dividend Per Share (Quarterly) (USD)|Singular Genomics Systems Inc Revenue (Quarterly) (USD)|Singular Genomics Systems Inc Gross Profit (Quarterly) (USD)|Singular Genomics Systems Inc SG&A Expense (Quarterly) (USD)|Singular Genomics Systems Inc Pre-Tax Income (Quarterly) (USD)|Singular Genomics Systems Inc Net Income (Quarterly) (USD)|Singular Genomics Systems Inc Net Interest Income (Quarterly) (USD)|Singular Genomics Systems Inc Price (USD)|Singular Genomics Systems Inc Total Return Price (USD)|Singular Genomics Systems Inc Enterprise Value (USD)|Singular Genomics Systems Inc 30-Day Average Daily Volume|Singular Genomics Systems Inc 1 Year Price Returns (Daily)||
new_0222_0430|OMIC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0430|OMIC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0430|OMIC|5|91|91||91||91|91|91||91|91||||1.44565217391||||1.43827160494|||1.44565217391||15.5||91|91||||||30.625|91.3333333333|91.5|91.3333333333|26.6666666667|91.25|91|||91.3333333333|91.3333333333|||91|||||91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44324324324|1.44324324324|1.44565217391|1.43870967742|||
new_0222_0430|OMIC|6|3|3||3||3|3|3||3|3||||184||||162|||184||16||3|3||||||8|6|2|6|6|4|3|||6|6|||3|||||6|6|6|6|185|185|184|155|||
new_0222_0430|OMIC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0430|OMIC|202003||||||||||||||||||||||||||||||||||69.3823||-0.0757||||||-0.0757|-0.01||||||||1.377|-5.253|-5.253|0.15|||||||
new_0222_0430|OMIC|202006||||||||||||||||||||||||||||||||||69.3823||-0.0987||||||-0.0987|0.01||||||||1.443|-6.847|-6.847|-0.079|||||||
new_0222_0430|OMIC|202009||||||||||||||||||||||||||||||||||69.3823||-0.1143||-0.03||||-0.1136|||||||||1.698|-7.933|-7.933|-0.126|||||||
new_0222_0430|OMIC|202012|27.571|26.919||2.368||82.057|3.69|78.367||-51.555|-53.125|||||||||||||||0.427|0.001|||||||69.3823||-0.114|||68.041|||-0.1119|-0.047|||-27.945|||||1.769|-7.912|-7.912|-0.154|||||||
new_0222_0430|OMIC|202103|151.506|150.121||2.75||228.965|7.906|221.059||-73.342|-77.046||||-60.5189|||||||||||0.657|0.001||||||2.1385|69.3823|138|-0.345|69.3823||68.041|||-0.3133|-2.984|||-46.613|||||3.654|-23.921|-23.921|-0.057|27|27|1874.5741||||
new_0222_0430|OMIC|202106|378.869|371.668||3.434||17.402|8.152|9.25||366.578|-114.525||||-39.0024||||5.3619|||||0.4362||2.698|0.007||||||69.8753|31.6289|169|-1.18|71.5263||71.5263|||-1.1807|-235.66|||-77.245|||||6.201|-37.479|-37.479|0.181|27.48|27.48|1603.4297|143930.2333||18.05|16.53
new_0222_0430|OMIC|202109|364.227|357.013||4.917||18.763|5.991|12.772||352.068|-132.136||||-9.8836||||2.2863|||||1.2089||2.39|0.007||||||54.2392|71.7219|200|-0.25|71.9342||71.9342|||-0.25|1.445|||-86.923|||||8.551|-17.611|-17.611|-0.143|11.19|11.19|457.7987|176657.8||13.85|11.42
new_0222_0430|OMIC|202112|||||||||||||||-10.4892||||2.366|||||1.597|||||||||56.574||||||||||||||||||||||11.56|11.56|485.8513|373322.2||7.75|6.99